Usability, Immediate, and 30 Day Effect of External Neuromodulation With iTEAR100 Generation 2 in Dry Eye Patients

Status unconfirmed · Phase 4

Conditions studied: Dry Eye

In brief

iTEAR generation 2 will be supplied t eligible subjects at Day 0. At Day 30, symptom questionnaires and ophthalmic exam will be performed.

Key facts

Study ID

NCT05304637

Run by

Olympic Ophthalmics, Inc.

People needed

30

Starts

2022-03-01

Expected to finish

2022-07-01

Last updated by the study team

2022-03-31

Who can join

Age: 21 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Dry eye

You may not qualify if…

• unable to read consent
• investigator discretion

Where it is running

• Olympic Ophthalmics — Issaquah, Washington, United States (enrolling)
• Periman Eye Institute — Seattle, Washington, United States (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.